Structural-Electronic Properties and Antioxidant Relations—A Case of DFT Study

Total Page:16

File Type:pdf, Size:1020Kb

Structural-Electronic Properties and Antioxidant Relations—A Case of DFT Study Hindawi Journal of Chemistry Volume 2019, Article ID 4360175, 12 pages https://doi.org/10.1155/2019/4360175 Research Article Isoflavones and Isoflavone Glycosides: Structural-Electronic Properties and Antioxidant Relations—A Case of DFT Study Son Ninh The ,1 Thanh Do Minh,2 and Trang Nguyen Van 2 1Institute of Natural Products Chemistry, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Caugiay, Hanoi, Vietnam 2Institute for Tropical Technology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet, Caugiay, Hanoi, Vietnam Correspondence should be addressed to Son Ninh e; [email protected] and Trang Nguyen Van; [email protected] Received 8 January 2019; Revised 13 February 2019; Accepted 24 February 2019; Published 24 June 2019 Academic Editor: Artur M. S. Silva Copyright © 2019 Son Ninh e et al. is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Isoflavonoids and isoflavonoid glycosides have drawn much attention because of their antioxidant radical-scavenging capacity. Based on computational methods, we now present the antioxidant potential results of genistein (1), biochanin A (2), ambocin (3), and tectorigenin 7-O-[β-D-apiofuranosyl-(1-6)-β-D-glucopyranoside] (4). e optimized structures of the neutral and radical forms have been determined by the DFT-B3LYP method with the 6-311G(d) basis set. From the findings and thermodynamic point of view, the ring B system of isoflavones is considered as an active center in facilitating antioxidant reactions. Antioxidant activities are mostly driven by O-H bond dissociation enthalpy (BDE) following hydrogen atom transfer (HAT) mechanism. Antioxidant ability can be arranged in the following order: compounds (4) > (3) > (2) > (1). Of comprehensive structural analysis, flavonoids with 4′-meth- ylation and 6-methoxylation, especially 7-glycosylation would claim responsibility for antioxidant enhancement. 1. Introduction apiofuranosyl-(1-6)-β-D-glucopyranoside] (4) (Figure 1) [4, 5]. A vast data showed that the substitutions at C-5, C-7, and C-4′ Naturally occurring isoflavone compounds fall into the class of in isoflavonoid rings have been playing a key role in structural flavonoid phenolic compounds, which consists of a molecular features of bioactive isoflavones, especially in terms of anti- structure of 3-phenylchromen-4-one backbone, and are widely oxidants [4]. For instance, genistein (1) revealed much more distributed in the plant kingdom, particularly in Fabaceae significance in the powerful antioxidant when compared to family [1]. Isoflavone derivatives were found to involve in other isoflavones like daidzein and glycitein due to the de- various biological experiments and have been employed in pendence on its functional hydroxyl groups [5]. Likewise, a pharmacological drugs to treat cancer, Alzheimer’s disease, survey conducted by Dowling et al. proposed that with regards atherosclerosis, and so on [2]. Basically, the reactive oxygen to DPPH (2,2-diphenyl-1-picrylhydrazyl) assay, both genstein radicals such as hydroxyls (·OH) presenting in living organ- (1) and its 4′-methoxylation biochanin A (2) successfully isms can be seen as the reason for the changes in the body and chelated to Cu (II) and Fe (III) with a 1 : 2 M/L stoichiometry in one of the main causes of various diseases [3]. Numerous methanol phase, whereas daidzein fails to do so [6]. evidence suggests that either flavonoids or typical isoflavones Using B3LYP functional with 6-311G(d) basis set for have been shown to be associated with good antioxidant studied mediums gas and methanol, the current DFT capacities due to their radical-scavenging activities. (density functional theory) study will provide an insight into Of computational compounds 1–4, we herein select the best structural features, conformational analyses, and electronic isoflavones and their 7-glycosylation principally based on the properties of the selective isoflavones 1-2, in which the result good results in their biological experiments, including genistein intensively related to explaining their reactivity with free (1), biochanin A (2), ambocin (3), and tectorigenin 7-O-[β-D- radicals. Ambocin (3) was isolated from the root of Pueraria 2 Journal of Chemistry HO 8a O θ HO 5′′′ 2 2 7 ′′′ O AC3 ′ 4 ′′′ 1′ 2 1 4a 2′′′ O 5 4 B ″ ′ OHOH 6 OH O 4 ″O OR HO 5″ 2 ″ 2 HO 1 O 8a O θ OH 2 1 R = H 7 2 ′ 2 R = Me 3 2 1′ 4a 4 R 5 ′ OH O 4 OH 3 R = H 4 R = OMe (a) (b) Figure 1: General structures of studied compounds 1–4 with atom numbering. mirica, while its 6-methoxylation compound (4) had re- (2) SET-PT pathway was recognized by two steps cently been identied as a new compound existing in (Equation (3)). In details, the rst step accounted Dalbergia sissoo stem bark [4, 7]. To the best of our for the process of losing an electron to form mo- knowledge, there have been no specic theoretically useful lecular radical cation Flav-OH•+. After that, Flav- account reports on their glycosides 3-4. erefore, we also OH•+ was deprotonated. e rst action was set out a computational work on 7-glycosylated compound evaluated by the sum of the ionization potential (3) and 6-methoxylated-7-glycosylated compound (4), (IP), whereas deprotonation was characterized by within the aim of nding the eects of chemical structure on heterolytic bond dissociation enthalpy (PDE) the antioxidant capacity. Hopefully, the ndings will lay the (Equations (4) and (5)). ground for future research. • • Flav-OH R Flav-OH + R + + Flav-O• ROH− ( ) 1.1. eoretical Parameters and Computational Procedure. ⟶ + DFT calculation is carried out with Gaussian 09 software • 3 IP ⟶H Flav-OH + He package [8]. In order to optimize the structure, the B3LYP + () H Flav-OH − ( ) exchange correlation functional level without constraints ( ) has been utilized and has been linked to 6-311G(d) basis set • 4 in the gas phase (dielectric constant, ε 1) and in methanol PDE −H Flav-O HH+ + solvent (ε 32.613) [9, 10]. Vibrational frequencies are • H Flav-OH + ( ) calculated at the same level to correct zero-point energy (ZPE). e result conrms the presence of ground states •+ 5 H(Flav-OH ) presents− the enthalpies of avonoid without imaginary frequency. e self-consistent reaction radical cation Flav-OH•+ after electron abstraction of eld polarizable continuum model (SCRF-PCM) has been original avonoid. e calculated gaseous phase employed for estimating solvent eects [9]. enthalpy values, which are 0.75 kcal/mol and From literature, there have been three known mecha- 1.48 kcal/mol, are normally used for H(e–) and nisms HAT (H-atom Transfer), SET-PT (Single electron H(H+), respectively [11, 12]. transfer-proton transfer), and SPLET (Sequential proton loss electron transfer), which concern radical-scavenging (3) e third mechanical SPLET is briey described properties of the parent molecular (Flav-OH) [11–17]: when avonoid is deprotonated to aord a typical anion Flav-O– and the sequential electron transfer (1) HAT mechanical route (Equation (1)) involves in from this anion happens (Equation (6)). Proton O-H bond breaking of Flav-OH, then transfers to a¤nity (PA) and the electron transfer enthalpy radicals, and is often controlled by homolytic bond (ETE) are two conceptual parameters which corre- dissociation enthalpy (BDE) (Equation (2)). spond to deprotonation and electron transfer, re- spectively (Equations (7) and (8)). Flav-OH RO• Flav-O• ROH + + ( ) • Flav-OH Flav-O H+; Flav-O R • • + + BDE ⟶H Flav-O HH 1 • + Flav-O− R ;R H−+ RH H Flav-OH ( ) ⟶ + + ( ) − − ( ) • • 2 ⟶ ⟶ H(Flav-O ), H(H ),− and H(Flav-OH) are the en- • PA H Flav-O HH+ thalpies of Flav-O , hydrogen radical atom, and the ()+ 6 H Flav-OH− ( ) parent avonoid molecule, respectively. ( ) 7 − Journal of Chemistry 3 + · − − associate with nucleophilic (fk ), electrophilic (fk ), and/or ETE � H Flav-O � + H() e 0 − (8) radical attacks (fk) and were possibly described by the − H() Flav-O following equilibriums [20]: f+ � q (N + ) q (N); H(Flav-O−) is the enthalpy of flavonoid anion after k k 1 − k proton abstraction of original molecule. f− � q (N) − q (N − 1); k k k (11) Antioxidant activities have been explained by DFT-based reactivity descriptors [11], including energies of highest oc- �q (N + 1) − q (N − 1)� f0 � k k ; cupied molecular orbital (HOMO) and lowest unoccupied k 2 molecular orbital (LUMO), dipole moments, atomic charges, where qk(N): electronic population of atom k in a neutral electron affinity A, the ionization potential Io, the global hardness η, the electronegativity χ, the chemical potential µ, molecule, qk(N + 1): electronic population of atom k in an global electrophilicity index ω, and Fukui chemical parameters. anionic molecule, and qk(N − 1): electronic population of Based on the theoretical approach of DFT, Janak’s atom k in a cationic molecule. theorem, and the finite difference approximation, these descriptors can be proposed by the related equations given as 2. Results and Discussion follows [18]: 2.1. Geometrical Analysis. e comprehension of isoflavone conformational analysis is an important method to prove the Io ≈ −EH; relationship between the antioxidant activities and structural A ≈ −EL; aspects since the HAT, SET-PT, and SPLETpathways closely depend on the behaviors of differential hydroxyl groups and Io − A � EL − EH � the geometric features. From Figures 2 and S1 and Table 1, η ≈ ≈ ; we reported the optimized structures with patterns of 2 2 (9) intramolecular hydrogen bonds (IHBs) between 5-OH and I + A � E + E � 4-CO, along with selective characters of bonds, bond angles, χ ≈ o ≈ L H ; 2 2 and dihedral angles. As of local minimum energies, there is no distinction in each compound between gaseous state and I + A � −E + E � methanol (Table 2).
Recommended publications
  • IN SILICO ANALYSIS of FUNCTIONAL Snps of ALOX12 GENE and IDENTIFICATION of PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS
    Tulasidharan Suja Saranya et al. Int. Res. J. Pharm. 2014, 5 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 – 8407 Research Article IN SILICO ANALYSIS OF FUNCTIONAL SNPs OF ALOX12 GENE AND IDENTIFICATION OF PHARMACOLOGICALLY SIGNIFICANT FLAVONOIDS AS LIPOXYGENASE INHIBITORS Tulasidharan Suja Saranya, K.S. Silvipriya, Manakadan Asha Asokan* Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Viswa Vidyapeetham University, AIMS Health Sciences Campus, Kochi, Kerala, India *Corresponding Author Email: [email protected] Article Received on: 20/04/14 Revised on: 08/05/14 Approved for publication: 22/06/14 DOI: 10.7897/2230-8407.0506103 ABSTRACT Cancer is a disease affecting any part of the body and in comparison with normal cells there is an elevated level of lipoxygenase enzyme in different cancer cells. Thus generation of lipoxygenase enzyme inhibitors have suggested being valuable. Individual variation was identified by the functional effects of Single Nucleotide Polymorphisms (SNPs). 696 SNPs were identified from the ALOX12 gene, out of which 73 were in the coding non-synonymous region, from which 8 were found to be damaging. In silico analysis was performed to determine naturally occurring flavonoids such as isoflavones having the basic 3- phenylchromen-4-one skeleton for the pharmacological activity, like Genistein, Diadzein, Irilone, Orobol and Pseudobaptigenin. O-methylated isoflavones such as Biochanin, Calycosin, Formononetin, Glycitein, Irigenin, 5-O-Methylgenistein, Pratensein, Prunetin, ψ-Tectorigenin, Retusin and Tectorigenine were also used for the study. Other natural products like Aesculetin, a coumarin derivative; flavones such as ajoene and baicalein were also used for the comparative study of these natural compounds along with acteoside and nordihydroguaiaretic acid (antioxidants) and active inhibitors like Diethylcarbamazine, Zileuton and Azelastine as standard for the computational analysis.
    [Show full text]
  • Global Journal of Medical Research
    Online ISSN : 2249 - 4618 Print ISSN : 0975 - 5888 Study of Cytological Pattern Development of Animal Models Polymorphism with breast cancer Histopathological and Toxicological effects Volume 12 | Issue 1 | Version 1.0 Global Journal of Medical Research Global Journal of Medical Research Volume 12 Issue 1 (Ver. 1.0) Open Association of Research Society © Global Journal of Medical Global Journals Inc. Research . 2012. (A Delaware USA Incorporation with “Good Standing”; Reg. Number: 0423089) Sponsors: Open Association of Research Society All rights reserved. Open Scientific Standards This is a special issue published in version 1.0 Publisher’s Headquarters office of “Global Journal of Medical Research.” By Global Journals Inc. Global Journals Inc., Headquarters Corporate Office, All articles are open access articles distributed Cambridge Office Center, II Canal Park, Floor No. under “Global Journal of Medical Research” 5th, Cambridge (Massachusetts), Pin: MA 02141 Reading License, which permits restricted use. Entire contents are copyright by of “Global United States Journal of Medical Research” unless USA Toll Free: +001-888-839-7392 otherwise noted on specific articles. USA Toll Free Fax: +001-888-839-7392 No part of this publication may be reproduced Offset Typesetting or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information Open Association of Research Society , Marsh Road, storage and retrieval system, without written permission. Rainham, Essex, London RM13 8EU United Kingdom. The opinions and statements made in this book are those of the authors concerned. Ultraculture has not verified and neither confirms nor denies any of the foregoing and Packaging & Continental Dispatching no warranty or fitness is implied.
    [Show full text]
  • Download Download
    Volume 3, Issue1, January 2012 Available Online at www.ijppronline.in International Journal Of Pharma Professional’s Research Review Article DALBERGIA SISSOO: AN OVERVIEW ISSN NO:0976-6723 Shivani saini*, Dr. Sunil sharma Guru Jambheshwar University of Science and Technology, Hisar, Haryana, India, 125001 Abstract The present review is, therefore, an effort to give a detailed survey of the literature on its pharamacognosy, phytochemistry, traditional uses and pharmacological studies of the plant Dalbergia sissoo. Dalbergia sissoo is an important timber species around the world. Besides this, it has been utilized as medicines for thousands of years and now there is a growing demand for plant based medicines, health products, pharmaceuticals and cosmetics. Dalbergia sissoo is a widely growing plant which is used traditionally as anti-inflammatory, antipyretic, analgesic, anti-oxidant, anti-diabetic and antimicrobial agent. Several phytoconstituents have been isolated and identified from different parts of the plant belonging tothe category of alkaloids, glycosides, flavanols, tannins, saponins, sterols and terpenoids. A review of plant description, phytochemical constituents present and their pharmacological activities are given in the present article. Keywords: - Dalbergia sissoo, phytochemical constituents, pharmacological activities. Introduction medicine.[7] To be accepted as viable alternative to Medicinal plants have been the part and parcel of modern medicine, the same vigorous method of human society to combat diseases since the dawn of scientific and clinical validation must be applied to human civilization. The earliest description of prove the safety and effectiveness of a therapeutic curative properties of medicinal plants were product.[ 8-9] described in the Rigveda (2500-1800 BC), Charak The genus, Dalbergia, consists of 300 species and Samhita and Sushruta Samhita.
    [Show full text]
  • Ep 3138585 A1
    (19) TZZ¥_¥_T (11) EP 3 138 585 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.03.2017 Bulletin 2017/10 A61L 27/20 (2006.01) A61L 27/54 (2006.01) A61L 27/52 (2006.01) (21) Application number: 16191450.2 (22) Date of filing: 13.01.2011 (84) Designated Contracting States: (72) Inventors: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB • Gousse, Cecile GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO 74230 Dingy Saint Clair (FR) PL PT RO RS SE SI SK SM TR • Lebreton, Pierre Designated Extension States: 74000 Annecy (FR) BA ME •Prost,Nicloas 69440 Mornant (FR) (30) Priority: 13.01.2010 US 687048 26.02.2010 US 714377 (74) Representative: Hoffmann Eitle 30.11.2010 US 956542 Patent- und Rechtsanwälte PartmbB Arabellastraße 30 (62) Document number(s) of the earlier application(s) in 81925 München (DE) accordance with Art. 76 EPC: 15178823.9 / 2 959 923 Remarks: 11709184.3 / 2 523 701 This application was filed on 29-09-2016 as a divisional application to the application mentioned (71) Applicant: Allergan Industrie, SAS under INID code 62. 74370 Pringy (FR) (54) STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES (57) The present specification generally relates to hydrogel compositions and methods of treating a soft tissue condition using such hydrogel compositions. EP 3 138 585 A1 Printed by Jouve, 75001 PARIS (FR) EP 3 138 585 A1 Description CROSS REFERENCE 5 [0001] This patent application is a continuation-in-part of U.S.
    [Show full text]
  • Bioactive Fractions and Compounds from Dalbergia
    (19) TZZ ZZ_T (11) EP 2 705 047 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C07H 17/07 (2006.01) A61K 31/7048 (2006.01) 05.08.2015 Bulletin 2015/32 C07D 311/36 (2006.01) A61K 31/352 (2006.01) A61P 19/10 (2006.01) (21) Application number: 12729239.9 (86) International application number: (22) Date of filing: 25.04.2012 PCT/IN2012/000301 (87) International publication number: WO 2012/147102 (01.11.2012 Gazette 2012/44) (54) BIOACTIVE FRACTIONS AND COMPOUNDS FROM DALBERGIA SISSOO FOR THE PREVENTION OR TREATMENT OF OSTEO-HEALTH RELATED DISORDERS BIOAKTIVE FRAKTIONEN UND VERBINDUNGEN AUS DALBERGIA SISSOO ZUR VORBEUGUNG ODER BEHANDLUNG KNOCHENZUSTANDSBEDINGTER ERKRANKUNGEN FRACTIONS ET COMPOSÉS BIOACTIFS ISSUS DE DALBERGIA SISSOO POUR PRÉVENIR OU TRAITER LES TROUBLES D’ORIGINE OSTÉOPATHIQUE (84) Designated Contracting States: • WAHAJUDDIN AL AT BE BG CH CY CZ DE DK EE ES FI FR GB Lucknow 226001 (IN) GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO • JAIN, Girish, Kumar PL PT RO RS SE SI SK SM TR Lucknow 226001 (IN) • CHATTOPADHYAY, Naibedya (30) Priority: 25.04.2011 IN DE12062011 Lucknow 226001 (IN) (43) Date of publication of application: (74) Representative: Jakobsson, Jeanette Helene 12.03.2014 Bulletin 2014/11 Awapatent AB P.O. Box 5117 (73) Proprietor: Council of Scientific & Industrial 200 71 Malmö (SE) Research New Delhi 110 001 (IN) (56) References cited: WO-A2-00/62765 WO-A2-2007/042010 (72) Inventors: FR-A1- 2 483 228 • MAURYA, Rakesh Lucknow 226001 (IN) • PREETY DIXIT ET AL: "Constituents of Dalbergia • DIXIT, Preety sissoo Roxb.
    [Show full text]
  • Natural Products As Chemopreventive Agents by Potential Inhibition of the Kinase Domain in Erbb Receptors
    Supplementary Materials: Natural Products as Chemopreventive Agents by Potential Inhibition of the Kinase Domain in ErBb Receptors Maria Olivero-Acosta, Wilson Maldonado-Rojas and Jesus Olivero-Verbel Table S1. Protein characterization of human HER Receptor structures downloaded from PDB database. Recept PDB resid Resolut Name Chain Ligand Method or Type Code ues ion Epidermal 1,2,3,4-tetrahydrogen X-ray HER 1 2ITW growth factor A 327 2.88 staurosporine diffraction receptor 2-{2-[4-({5-chloro-6-[3-(trifl Receptor uoromethyl)phenoxy]pyri tyrosine-prot X-ray HER 2 3PP0 A, B 338 din-3-yl}amino)-5h-pyrrolo 2.25 ein kinase diffraction [3,2-d]pyrimidin-5-yl]etho erbb-2 xy}ethanol Receptor tyrosine-prot Phosphoaminophosphonic X-ray HER 3 3LMG A, B 344 2.8 ein kinase acid-adenylate ester diffraction erbb-3 Receptor N-{3-chloro-4-[(3-fluoroben tyrosine-prot zyl)oxy]phenyl}-6-ethylthi X-ray HER 4 2R4B A, B 321 2.4 ein kinase eno[3,2-d]pyrimidin-4-ami diffraction erbb-4 ne Table S2. Results of Multiple Alignment of Sequence Identity (%ID) Performed by SYBYL X-2.0 for Four HER Receptors. Human Her PDB CODE 2ITW 2R4B 3LMG 3PP0 2ITW (HER1) 100.0 80.3 65.9 82.7 2R4B (HER4) 80.3 100 71.7 80.9 3LMG (HER3) 65.9 71.7 100 67.4 3PP0 (HER2) 82.7 80.9 67.4 100 Table S3. Multiple alignment of spatial coordinates for HER receptor pairs (by RMSD) using SYBYL X-2.0. Human Her PDB CODE 2ITW 2R4B 3LMG 3PP0 2ITW (HER1) 0 4.378 4.162 5.682 2R4B (HER4) 4.378 0 2.958 3.31 3LMG (HER3) 4.162 2.958 0 3.656 3PP0 (HER2) 5.682 3.31 3.656 0 Figure S1.
    [Show full text]
  • 中国科技论文在线 Pro-Apoptotic Effects of Tectorigenin on Human
    中国科技论文在线 http://www.paper.edu.cn Pro-apoptotic effects of tectorigenin on human hepatocellular carcinoma HepG2 cells# DING Hui, SHI Dahua, LI Erguang, WANG Yurong, JIANG Chunping, 5 WU Junhua** (Jiangsu Key Laboratory of Molecular Medicine, State Key Laboratory of Pharmaceutical Biotechnology, Medical School, Nanjing University, NanJing 210093) Abstract: Tectorigenin, a main isoflavone in the Iris tectorum rhizome which was used traditionally for treating liver-related diseases, was shown to inhibit the growth of human hepatoma HepG2 cells, 10 and to induce the cell apoptosis. In the apoptotic process, the intracellular ROS and Ca2+ elevation acted as an early event followed by depolarization of mitochondrial membrane potential (MMP). And then cytochrome c was released to cytosol. Moreover, the tectorigenin treatment co-enhanced the caspase-3, -8 and -9 proteolytic activities. In conclusion, tectorigenin significantly inhibited the proliferation and induced apoptosis in human hepatocellular carcinoma HepG2 cells mainly via 15 mitochondrial-mediated pathway. And the death receptor-dependent pathway might play a certain role in the apoptotic process. These observations indicated that tectorigenin is the active principle of Iris tectorum rhizome applied in the folk medicine for alleviating liver disorders, and that the isoflavone is a promising candidate for hepatocellular carcinoma chemotherapeutic and chemopreventive agent. Keywords: Tectorigenin; Anti-proliferation; Apoptosis; Mitochondrial; HepG2 20 0 Introduction Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide, with 600 000 deaths per year[1]. It often develops in patients with chronic liver diseases associated with hepatitis B (HBV) or hepatitis C (HCV) virus infections[1]. Although 25 surgical techniques have been improved and several non-surgical treatment modalities have been developed, there is no effective therapy for significant improvement of extremely poor prognosis of HCC patients[2].
    [Show full text]
  • ACHROM-2021.00936 Proof 1..7
    Pharmacokinetics of tectorigenin, tectoridi, irigenin, and iridin in mouse blood after intravenous administration by UPLC-MS/MS Acta Chromatographica JIANBO LI1, YUQI YAO2, MINYUE ZHOU2, ZHENG YU2, YINAN JIN2 and XIANQIN WANG2p DOI: 1 fi 10.1556/1326.2021.00936 The Second Af liated Hospital Zhejiang University School of Medicine Yuhang Campus, © 2021 The Author(s) Hangzhou, China 2 Analytical and Testing Centre, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, China Received: May 25, 2021 • Accepted: July 12, 2021 ORIGINAL RESEARCH PAPER ABSTRACT Tectorigenin, tectoridin, irigenin, and iridin are the four most predominant compounds present in She Gan. She Gan has been used in traditional Chinese medicine because of its anti-inflammatory, hep- atoprotective, anti-tumor, antioxidant, phytoestrogen-like properties. In this paper, a UPLC-MS/MS method was developed to measure the pharmacokinetics of tectorigenin, tectoridin, irigenin, iridin after intravenous administration in mice. A UPLC BEH C18 (50 mm 3 2.1 mm, 1.7 mm particle size) chro- matographic column was utilized for separation of the four target analytes and internal standard (IS), and the analysis of blood plasma samples; the mobile phase consisted of an acetonitrile-water (w/0.1% formic acid) gradient elution. Electron spray ionization (ESI) positive-ion mode and multiple reaction monitoring (MRM) mode was used for quantitative analysis of the analytes and internal standard. The four compounds were administered intravenously (sublingual) at doses of 5 mg/kg. After blood sam- pling, samples were processed and then analyzed by UPLC-MS/MS. The linearity of the method was robust over the concentration range of 2–5,000 ng/mL.
    [Show full text]
  • Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death Through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells
    molecules Article Iridin Induces G2/M Phase Cell Cycle Arrest and Extrinsic Apoptotic Cell Death through PI3K/AKT Signaling Pathway in AGS Gastric Cancer Cells Pritam-Bhagwan Bhosale 1 , Preethi Vetrivel 1, Sang-Eun Ha 1, Hun-Hwan Kim 1, Jeong-Doo Heo 2, Chung-Kil Won 1, Seong-Min Kim 1,* and Gon-Sup Kim 1,* 1 Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Gazwa, Jinju 52828, Korea; [email protected] (P.-B.B.); [email protected] (P.V.); [email protected] (S.-E.H.); [email protected] (H.-H.K.); [email protected] (C.-K.W.) 2 Biological Resources Research Group, Bioenvironmental Science & Toxicology Division, Korea Institute of Toxicology (KIT), 17 Jeigok-gil, Jinju 52834, Korea; [email protected] * Correspondence: [email protected] (S.-M.K.); [email protected] (G.-S.K.); Tel.: +82-10-3834-5823 (G.-S.K.) Abstract: Iridin is a natural flavonoid found in Belamcanda chinensis documented for its broad spectrum of biological activities like antioxidant, antitumor, and antiproliferative effects. In the present study, we have investigated the antitumor potential of iridin in AGS gastric cancer cells. Iridin treatment decreases AGS cell growth and promotes G2/M phase cell cycle arrest by attenuating the expression of Cdc25C, CDK1, and Cyclin B1 proteins. Iridin-treatment also triggered apoptotic cell death in AGS cells, which was verified by cleaved Caspase-3 (Cl- Caspase-3) and poly ADP-ribose Citation: Bhosale, P.-B.; Vetrivel, P.; polymerase (PARP) protein expression. Further apoptotic cell death was confirmed by increased Ha, S.-E.; Kim, H.-H.; Heo, J.-D.; apoptotic cell death fraction shown in allophycocyanin (APC)/Annexin V and propidium iodide Won, C.-K.; Kim, S.-M.; Kim, G.-S.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano Et Al
    US 20090269772A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0269772 A1 Califano et al. (43) Pub. Date: Oct. 29, 2009 (54) SYSTEMS AND METHODS FOR Publication Classification IDENTIFYING COMBINATIONS OF (51) Int. Cl. COMPOUNDS OF THERAPEUTIC INTEREST CI2O I/68 (2006.01) CI2O 1/02 (2006.01) (76) Inventors: Andrea Califano, New York, NY G06N 5/02 (2006.01) (US); Riccardo Dalla-Favera, New (52) U.S. Cl. ........... 435/6: 435/29: 706/54; 707/E17.014 York, NY (US); Owen A. (57) ABSTRACT O'Connor, New York, NY (US) Systems, methods, and apparatus for searching for a combi nation of compounds of therapeutic interest are provided. Correspondence Address: Cell-based assays are performed, each cell-based assay JONES DAY exposing a different sample of cells to a different compound 222 EAST 41ST ST in a plurality of compounds. From the cell-based assays, a NEW YORK, NY 10017 (US) Subset of the tested compounds is selected. For each respec tive compound in the Subset, a molecular abundance profile from cells exposed to the respective compound is measured. (21) Appl. No.: 12/432,579 Targets of transcription factors and post-translational modu lators of transcription factor activity are inferred from the (22) Filed: Apr. 29, 2009 molecular abundance profile data using information theoretic measures. This data is used to construct an interaction net Related U.S. Application Data work. Variances in edges in the interaction network are used to determine the drug activity profile of compounds in the (60) Provisional application No. 61/048.875, filed on Apr.
    [Show full text]
  • Anti-Helicobacter Pylori Compounds from Maackia Amurensis
    Natural Product Sciences 21(1) : 49-53 (2015) Anti-Helicobacter pylori Compounds from Maackia amurensis Woo Sung Park1, Ji-Yeong Bae1, Hye Jin Kim1, Min Gab Kim1, Woo-Kon Lee2, Hyung-Lyun Kang2, Seung-Chul Baik2, Kyung Mook Lim3, Mi Kyeong Lee4, and Mi-Jeong Ahn1,* 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Gyeongsang National University, Jinju 660-701, Korea 2Department of Microbiology, School of Medicine and Research Institute of Life Sciences, Gyeongsang National University, Jinju 660-751, Korea 3Cho-A Pharmaceutical Company, Seoul 150-902, Korea 4College of Pharmacy, Chungbuk National University, Cheongju 361-763, Korea Abstract − Eight isoflavonoid compounds were isolated from the EtOAc fraction of Maackia amurensis which had shown the highest anti-Helicobacter pylori activity among the fractions, using medium pressure liquid chromatography and recrystallization. Based on the spectroscopic data including 1H-NMR, 13C-NMR, HMBC and MS data, the chemical structures of the isolates were determined to be (−)-medicarpin (1), afromosin (2), formononetin (3), tectorigenin (4), prunetin (5), wistin (6), tectoridin (7) and ononin (8). Anti-H. pylori activity of each compound was evaluated with broth dilution assay. As a result, (−)-medicarpin (1), tectorigenin (4) and wistin (6) showed anti-H. pylori activity. (−)-Medicarpin (1) exhibited the most potent growth inhibitory activity against H. pylori with the minimal inhibitory concentration (MIC)90 of 25 µM, and tectorigenin (4) with MIC90 of 100 µM ranked the second. This is the first study to show the anti-H. pylori activity of M. amurensis, and it is suggested that the stem bark of M. amurensis or the EtOAc fraction or the isolated compounds can be a new natural source for the treatment of H.
    [Show full text]
  • Evaluation of the Estrogenic Activity of Pueraria (Kudzu) Flower Extract and Its Major Isoflavones Using ER-Binding and Uterotrophic Bioassays
    Pharmacology & Pharmacy, 2013, 4, 255-260 255 http://dx.doi.org/10.4236/pp.2013.42036 Published Online April 2013 (http://www.scirp.org/journal/pp) Evaluation of the Estrogenic Activity of Pueraria (Kudzu) Flower Extract and Its Major Isoflavones Using ER-Binding and Uterotrophic Bioassays Tomoyasu Kamiya1*, Akira Takano1, Yayoi Kido1, Yuki Matsuzuka1, Mayu Sameshima-Kamiya1, Masahito Tsubata1, Motoya Ikeguchi1, Kinya Takagaki1, Junei Kinjo2 1Research and Development Division, Toyoshinyaku Co. Ltd., Tosu-shi, Japan; 2Faculty of Pharmaceutical Sciences, Fukuoka Uni- versity, Fukuoka, Japan. Email: *[email protected] Received January 20th, 2013; revised March 5th, 2013; accepted April 14th, 2013 Copyright © 2013 Tomoyasu Kamiya et al. This is an open access article distributed under the Creative Commons Attribution Li- cense, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Pueraria flower extract (PFE) is a hot water extract of the Kudzu flower (Pueraria thomsonii). Tea made from dried Kudzu flower is widely used in China, and PFE is utilized as a nutritional supplement in Japan. PFE contains unique isoflavones such as 6-hydroxygenistein 6,7-di-O-glucoside (6HGDG), tectorigenin 7-O-xylosylglucoside (TGXG), and tectoridin. 6HGDG is known to be metabolized into 6-hydroxygenistein, and TGXG and tectoridin are known to be metabolized into tectorigenin in the digestive tract. Isoflavones typically mimic the effects β-estradiol has on estrogen receptors (ERs) and may influence the female genital system in the case of excessive intake. As a result, the upper limit of safe daily consumption of soy isoflavones has been enforced in Japan.
    [Show full text]